Tumour-localizing properties of porphyrins in vivo studies using free and liposome encapsulated aminolevulinic acid

1. 1. Using different doses of free and liposome encapsulated aminolevulinic acid (ALA) (between 2 and 8 mg/animal), given i.p., s.c. and intra-tumoural (i.t.), in vivo porphyrin synthesis by tumour, red blood cells (RBC) and different organs from tumour-bearing mice (TBM) and normal mice (NM) at di...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fukuda, Haydeé, Paredes, Sergio Raúl
Publicado: 1992
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03050491_v102_n2_p433_Fukuda
http://hdl.handle.net/20.500.12110/paper_03050491_v102_n2_p433_Fukuda
Aporte de:
id paper:paper_03050491_v102_n2_p433_Fukuda
record_format dspace
spelling paper:paper_03050491_v102_n2_p433_Fukuda2023-06-08T15:30:17Z Tumour-localizing properties of porphyrins in vivo studies using free and liposome encapsulated aminolevulinic acid Fukuda, Haydeé Paredes, Sergio Raúl aminolevulinic acid liposome porphyrin animal experiment animal tissue article cancer controlled study encapsulation intraperitoneal drug administration intratumoral drug administration mouse nonhuman priority journal subcutaneous drug administration tissue distribution tumor Aminolevulinic Acid Animal Drug Carriers Liposomes Male Mice Mice, Inbred BALB C Neoplasms, Experimental Organ Specificity Porphyrins Support, Non-U.S. Gov't Animalia 1. 1. Using different doses of free and liposome encapsulated aminolevulinic acid (ALA) (between 2 and 8 mg/animal), given i.p., s.c. and intra-tumoural (i.t.), in vivo porphyrin synthesis by tumour, red blood cells (RBC) and different organs from tumour-bearing mice (TBM) and normal mice (NM) at different times, up to 24 hr after ALA administration, was examined. 2. 2. It was found that by giving entrapped ALA, at a dose of 6 mg/animal (or 200 mg/kg wt), after 10 hr, a high level of porphyrin accumulation in the tumour was produced (7 μg/g tissue). Low synthesis occurred in muscle, lung, brain, RBC and skin; in spleen, kidney and liver synthesis is significant after 10 hr, but after 24 hr returned to normal values in the spleen and to about 2-3 μg/g tissue in the kidney and liver. 3. 3. The tumour/skin porphyrin concentration ratio after 10 hr was nearly 30, the highest so far reported. 4. 4. These results support our previous in vitro findings, indicating that free or encapsulated ALA might be used for early diagnosis of cancer and in photodynamic therapy. © 1992. Fil:Fukuda, H. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Paredes, S. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 1992 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03050491_v102_n2_p433_Fukuda http://hdl.handle.net/20.500.12110/paper_03050491_v102_n2_p433_Fukuda
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic aminolevulinic acid
liposome
porphyrin
animal experiment
animal tissue
article
cancer
controlled study
encapsulation
intraperitoneal drug administration
intratumoral drug administration
mouse
nonhuman
priority journal
subcutaneous drug administration
tissue distribution
tumor
Aminolevulinic Acid
Animal
Drug Carriers
Liposomes
Male
Mice
Mice, Inbred BALB C
Neoplasms, Experimental
Organ Specificity
Porphyrins
Support, Non-U.S. Gov't
Animalia
spellingShingle aminolevulinic acid
liposome
porphyrin
animal experiment
animal tissue
article
cancer
controlled study
encapsulation
intraperitoneal drug administration
intratumoral drug administration
mouse
nonhuman
priority journal
subcutaneous drug administration
tissue distribution
tumor
Aminolevulinic Acid
Animal
Drug Carriers
Liposomes
Male
Mice
Mice, Inbred BALB C
Neoplasms, Experimental
Organ Specificity
Porphyrins
Support, Non-U.S. Gov't
Animalia
Fukuda, Haydeé
Paredes, Sergio Raúl
Tumour-localizing properties of porphyrins in vivo studies using free and liposome encapsulated aminolevulinic acid
topic_facet aminolevulinic acid
liposome
porphyrin
animal experiment
animal tissue
article
cancer
controlled study
encapsulation
intraperitoneal drug administration
intratumoral drug administration
mouse
nonhuman
priority journal
subcutaneous drug administration
tissue distribution
tumor
Aminolevulinic Acid
Animal
Drug Carriers
Liposomes
Male
Mice
Mice, Inbred BALB C
Neoplasms, Experimental
Organ Specificity
Porphyrins
Support, Non-U.S. Gov't
Animalia
description 1. 1. Using different doses of free and liposome encapsulated aminolevulinic acid (ALA) (between 2 and 8 mg/animal), given i.p., s.c. and intra-tumoural (i.t.), in vivo porphyrin synthesis by tumour, red blood cells (RBC) and different organs from tumour-bearing mice (TBM) and normal mice (NM) at different times, up to 24 hr after ALA administration, was examined. 2. 2. It was found that by giving entrapped ALA, at a dose of 6 mg/animal (or 200 mg/kg wt), after 10 hr, a high level of porphyrin accumulation in the tumour was produced (7 μg/g tissue). Low synthesis occurred in muscle, lung, brain, RBC and skin; in spleen, kidney and liver synthesis is significant after 10 hr, but after 24 hr returned to normal values in the spleen and to about 2-3 μg/g tissue in the kidney and liver. 3. 3. The tumour/skin porphyrin concentration ratio after 10 hr was nearly 30, the highest so far reported. 4. 4. These results support our previous in vitro findings, indicating that free or encapsulated ALA might be used for early diagnosis of cancer and in photodynamic therapy. © 1992.
author Fukuda, Haydeé
Paredes, Sergio Raúl
author_facet Fukuda, Haydeé
Paredes, Sergio Raúl
author_sort Fukuda, Haydeé
title Tumour-localizing properties of porphyrins in vivo studies using free and liposome encapsulated aminolevulinic acid
title_short Tumour-localizing properties of porphyrins in vivo studies using free and liposome encapsulated aminolevulinic acid
title_full Tumour-localizing properties of porphyrins in vivo studies using free and liposome encapsulated aminolevulinic acid
title_fullStr Tumour-localizing properties of porphyrins in vivo studies using free and liposome encapsulated aminolevulinic acid
title_full_unstemmed Tumour-localizing properties of porphyrins in vivo studies using free and liposome encapsulated aminolevulinic acid
title_sort tumour-localizing properties of porphyrins in vivo studies using free and liposome encapsulated aminolevulinic acid
publishDate 1992
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03050491_v102_n2_p433_Fukuda
http://hdl.handle.net/20.500.12110/paper_03050491_v102_n2_p433_Fukuda
work_keys_str_mv AT fukudahaydee tumourlocalizingpropertiesofporphyrinsinvivostudiesusingfreeandliposomeencapsulatedaminolevulinicacid
AT paredessergioraul tumourlocalizingpropertiesofporphyrinsinvivostudiesusingfreeandliposomeencapsulatedaminolevulinicacid
_version_ 1768544912692740096